Predictive Value of DICA in the Diverticular Disease of the Colon
NCT ID: NCT02758860
Last Updated: 2022-05-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2215 participants
OBSERVATIONAL
2016-06-30
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the study is to show that DICA classification is a valid parameter to predict the risk of acute diverticulitis occurrence/recurrence and the need of surgery in patients suffering from diverticulosis/diverticular disease of the colon.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Observational Analysis of Circulating Endocan Levels in Patients Presenting With Acute Diverticulitis
NCT07027007
Impact of Diverticular Disease on the Detection of Colon Adenomas
NCT02057562
Confocal Laser Endomicrospy in Colonic Diverticular Disease
NCT04173182
Backwards Examination of the Right Colon: A Back-to-back Study
NCT02838186
Detection of Adenomas in Screening Colonoscopy
NCT04651062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A recent multicentre, international, retrospective study found that DICA classification has a significant predictive value on the outcome of the disease in terms of acute diverticulitis occurrence/recurrence and surgery occurrence.
The aim of the present study is to confirm the above mentioned results propectively Several centers, worldwide distributed, will be involved. A minimum of 281 patients will be required for the study. This calculation will be based on the assumption that a continuity-corrected chi-square test with a type I error of 0.05 and a type II error of 0.20 will be expected to detect a difference between a 4.3% prevalence of diverticulitis in patients with diverticulosis and 8.6% in DICA I patients.
Only patients at the first endoscopic diagnosis of diverticulosis/diverticular disease will be enrolled. For each patient, we recorded: age; severity of DICA score; severity of symptoms at entry and during the follow-up; C-reactive protein (CRP) and fecal calprotectin test at the time of diagnosis and during the follow-up (CRP only for DICA 2 and 3 patients); comorbidities (if any); concomitant therapies (if any); therapy taken during the follow-up to maintain remission (if any); months of follow-up; occurrence/recurrence of acute diverticulitis; need of surgery.
The study will take three year. The investigators aim at confirming that DICA classification is a valid parameter to predict the risk of acute diverticulitis occurrence/recurrence and the need of surgery in patients suffering from diverticulosis/diverticular disease of the colon. This could permit to select populations at higher or lower risk, having or not benefit from scheduled (and type) treatment able to reduce those risks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colonoscopy
Patients will be submitted to diagnostic colonoscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Inflammatory bowel diseases;
* Ischemic colitis;
* Prior colonic resection
* Patients with severe liver failure (Child-Pugh C);
* Patients with severe kidney failure;
* Pregnant women;
* Women of childbearing potential not using a highly effective method of contraception;
* Patients who are currently using or who have received any laxative agents \< 2 weeks prior to the enrollment;
* Patients who are currently using or who have received mesalamine compounds \< 2 weeks prior to the enrollment;
* Patients who are currently using or who have received any probiotic agents \< 2 weeks prior to the enrollment;
* Nonsteroidal anti-inflammatory drug (NSAID) use \< 1 week prior to the enrollment;
* Patients who have received treatment with antibiotics (even those not absorbed) \< 2 weeks prior to the enrollment;
* Inability to comply with study protocol and to give informed consensus to the procedure;
* Patients with or history of cancer, of any origin, within 5 years before enrollment
* History of alcohol, drug, or chemical abuse
* Any severe pathological condition that may interfere with the proper study execution.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Roma La Sapienza
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erasmo Spaziani
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antonio Tursi, MD
Role: PRINCIPAL_INVESTIGATOR
Gastroenterology Service , ASL BAT, Andria (BT) - Italy
Giovanni Brandimarte, MD
Role: STUDY_DIRECTOR
UOC di Medicina Interna, Servizio di Endoscopia Digestiva, Ospedale "Cristo Re" Rome
Walter Elisei, MD
Role: PRINCIPAL_INVESTIGATOR
UOC di Gastroenterologia, ASL Roma 6 Albano Laziale (Rome)
Marcello Picchio, MD
Role: PRINCIPAL_INVESTIGATOR
UOC di Chirurgia Generale, Ospedale "P. Colombo", ASL Roma 6 Velletri (Rome)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Av, 470 - Hosp Ort de Goiania (St Aeroporto)
Goiânia, Goiás, Brazil
Consultório R, 46 - 25 Clin de Gastroentero
Goiânia, Goiás, Brazil
UOC di Gastroenterologia, Ospedale "San Pio da Pietrelcina"
Vasto, Chieti, Italy
Sapienza University of Rome- Polo Pontino
Terracina, Latina, Italy
UOC di Gastroenterologia, Ospedale "Santa Caterina Novella"
Galatina, Lecce, Italy
Servizio Gastroenterologia ed Endoscopia Digestiva, Casa di Cura "Villa dei Pini"
Civitanova Marche, Macerata, Italy
IBD Unit, Ospedale Universitario "Humanitas"
Rozzano, Milan, Italy
UOC di Gastroenterologia, Policlinico "San Donato"
San Donato Milanese, Milan, Italy
UO di Endoscopia Digestiva, Nuovo Ospedale Civile "Sant'Agostino Estense"
Baggiovara, Modena, Italy
UOC di Gastroenterologia, Ospedale "T. Maresca"
Torre del Greco, Napoli, Italy
SS di Endoscopia Digestiva, Ospedale "San Matteo degli Infermi" Spoleto (PG)
Spoleto, Perugia, Italy
Servizio di Gastroenterologia ed Endoscopia Digestiva, Casa della Salute Magliano Sabina
Magliano Sabina, Rieti, Italy
UOC di Gastroenterologia, ASL Roma 6
Albano Laziale, Roma, Italy
UOC di Gastroenterologia ed Endoscopia Chirurgica, Ospedale "Grassi"
Ostia Antica, Rome, Italy
UOC di Chirurgia Generale, Ospedale "P. Colombo", ASL Roma 6
Velletri, Rome, Italy
SSD di Endoscopia Digestiva, Ospedale "Valle d'Itria
Martina Franca, Taranto, Italy
UO Endoscopia Digestiva, ULSS4 Alto Vicentino,
Santorso, Vicenza, Italy
UOSD di Endoscopia Digestiva, Ospedale di Tarquinia
Tarquinia, Viterbo, Italy
Gastroenterology Service , ASL BAT,
Andria, , Italy
Sezione di Medicina Interna, Clinica Medica "A. Murri", Policlinico Consorziale
Bari, , Italy
UOC di Gastroenterologia, Ospedale "San Paolo"
Bari, , Italy
UO di Gastroenterologia - Policlinico del Monserrato, Università di Cagliari
Cagliari, , Italy
UOC di Gastroenterologia, Ospedale "Pugliese-Ciaccio"
Catanzaro, , Italy
U.O.D. di Endoscopia Digestiva, Ospedale "S. Maria Goretti"
Latina, , Italy
UOC di Gastroenterologia, Ospedale "San Salvatore", Università de L'Aquila L'Aquila
L’Aquila, , Italy
UOC di Gastroenterologia, A.O. "L. Sacco" , Università di Milano
Milan, , Italy
UOS di Gastroenterologia ed Endoscopia Digestiva- Ospedale "Bucchieri - La Ferla"
Palermo, , Italy
UO di Gastroenterologia - Ospedale Maggiore, Università di Parma
Parma, , Italy
Dipartimento di medicina Clinica e Sperimentale, Sezione di Gastroenterologia ed Epatologia Ospedale "Santa Maria della Misericordia" Hospital, Università di Perugia,
Perugia, , Italy
SC di Gastroenterologia - Endoscopia Digestiva, IRCCS Arcispedale "Santa Maria Nuova"
Reggio Emilia, , Italy
UOD di Endoscopia Digestiva e Nutrizionale, Ospedale "S. Eugenio"
Rome, , Italy
UOC di Chirurgia Generale "I", Policlinico "Umberto I", Università "Sapienza"
Rome, , Italy
UOC di Medicina Interna, Servizio di Endoscopia Digestiva, Ospedale "Cristo Re" Roma
Rome, , Italy
UOC di Medicina Interna e Gastroenterologia, C.I. "Columbus", Università Cattolica
Rome, , Italy
UOC di Medicina Interna e Gastroenterologia, Policlinico "A. Gemelli"
Rome, , Italy
UOC di Gastroenterologia ed Endoscopia Digestiva, A.O. "S. Giovanni-Addolorata"
Rome, , Italy
Servizio di Gastroenterologia ed Endoscopia Digestiva, PTP "Nuovo Regina Margherita"
Rome, , Italy
UOC di Gastroenterologia, Ospedale "Molinette"
Turin, , Italy
UOC di Gastroenterologia, Ospedale "Santa Maria della Misericordia"
Udine, , Italy
UOC di Gastroenterologia, Ospedale "Belcolle"
Viterbo, , Italy
Centre for abdominal surgery, Vilnius University Hospital Santariskiu Klinikos,
Vilnius, , Lithuania
Department of Gastroenterology, Hepatology and Clinical Oncology, Medical Postgraduate Education Centre; Department of Gastrointestinal Oncology, Maria Sklodowska-Curie Clinical Oncology Institute
Warsaw, , Poland
2nd Medical Department, Iuliu Hatieganu University of Medicine and Pharmacy
Cluj-Napoca, Cluj, Romania
Department of Colorectal Surgery, Kings College Hospital,
London, , United Kingdom
Universidad Central de Venezuela, Loira Medical Center,
Caracas, , Venezuela
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tursi A, Brandimarte G, Di Mario F, Andreoli A, Annunziata ML, Astegiano M, Bianco MA, Buri L, Cammarota G, Capezzuto E, Chilovi F, Cianci M, Conigliaro R, Del Favero G, Di Cesare L, Di Fonzo M, Elisei W, Faggiani R, Farroni F, Forti G, Germana B, Giorgetti GM, Giovannone M, Lecca PG, Loperfido S, Marmo R, Morucci P, Occhigrossi G, Penna A, Rossi AF, Spadaccini A, Zampaletta C, Zilli M, Zullo A, Scarpignato C, Picchio M. Development and validation of an endoscopic classification of diverticular disease of the colon: the DICA classification. Dig Dis. 2015;33(1):68-76. doi: 10.1159/000366039. Epub 2014 Dec 17.
Tursi A, Brandimarte G, Di Mario F, Elisei W, Picchio M, Allegretta L, Annunziata ML, Bafutto M, Bassotti G, Bianco MA, Colucci R, Conigliaro R, Dumitrascu D, Escalante R, Ferrini L, Forti G, Franceschi M, Graziani MG, Lammert F, Latella G, Maconi G, Nardone G, Camara de Castro Oliveira L, Chaves Oliveira E, Papa A, Papagrigoriadis S, Pietrzak A, Pontone S, Poskus T, Pranzo G, Reichert MC, Rodino S, Regula J, Scaccianoce G, Scaldaferri F, Vassallo R, Zampaletta C, Zullo A, Piovani D, Bonovas S, Danese S; DICA International Group. Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study. Gut. 2022 Jul;71(7):1350-1358. doi: 10.1136/gutjnl-2021-325574. Epub 2021 Oct 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DICA Trial
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.